Patents by Inventor Mohan Vishwaraman
Mohan Vishwaraman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 8835415Abstract: The present disclosure is in relation to antiviral preparations obtained from plant sources namely Cinnamon, Litchi and Arachis. It provides a composition and a process to prepare the composition comprising pentameric procyanidin flavonoid, trimers and tetramers. The composition improves immunity response and found to be useful in treatment and management of HIV infection and AIDS and for the prevention, treatment and management of Influenza virus and infection.Type: GrantFiled: September 24, 2009Date of Patent: September 16, 2014Assignee: Indus Biotech Private LimitedInventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Publication number: 20140187624Abstract: The present disclosure is related to management of chemotherapy induced side effects namely cachexia and alopecia by administering a pharmaceutical composition comprising pentameric type A procyanidin flavonoid, trimeric procyanidin flavonoid and tetrameric procyanidin flavonoid, optionally along with pharmaceutical excipients.Type: ApplicationFiled: July 17, 2012Publication date: July 3, 2014Applicant: INDUS BIOTECH PRIVATE LIMITEDInventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Publication number: 20140107167Abstract: The present invention relates to a pharmaceutical composition having dopaminergic activity and other related pharmaceutical activities comprising trigonelline or its derivative(s) and 4-hydroxyisoleucine or its derivative(s), optionally along with excipients(s); a process of preparing a pharmaceutical composition comprising trigonelline or its derivative(s) and 4-hydroxyisoleucine or its derivative(s), optionally along with excipients(s), wherein the process comprising steps of: (a) extracting a clear solution containing trigonelline and 4-hydroxyisoleucine from plant source; and (b) optionally precipitating derivative(s) of trigonelline and 4-hydroxyisoleucine from the clear solution and obtaining said composition; and an in-vitro method to increase levels of dopamine or to inhibit prolactin by allowing composition comprising trigonelline or its derivative(s) and 4-hydroxyisoleucine or its derivative(s) to bind to cell receptors.Type: ApplicationFiled: December 12, 2013Publication date: April 17, 2014Applicant: INDUS Biotech PVT. Ltd.Inventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Patent number: 8633229Abstract: The present invention relates to a pharmaceutical composition having dopaminergic activity and other related pharmaceutical activities comprising trigonelline or its derivative(s) and 4-hydroxyisoleucine or its derivative(s), optionally along with excipients(s); a process of preparing a pharmaceutical composition comprising trigonelline or its derivative(s) and 4-hydroxyisoleucine or its derivative(s), optionally along with excipients(s), wherein the process comprising steps of: (a) extracting a clear solution containing trigonelline and 4-hydroxyisoleucine from plant source; and (b) optionally precipitating derivative(s) of trigonelline and 4-hydroxyisoleucine from the clear solution and obtaining said composition; and an in-vitro method to increase levels of dopamine or to inhibit prolactin by allowing composition comprising trigonelline or its derivative(s) and 4-hydroxyisoleucine or its derivative(s) to bind to cell receptors.Type: GrantFiled: March 3, 2008Date of Patent: January 21, 2014Assignee: INDUS Biotech Pvt. Ltd.Inventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Patent number: 8563601Abstract: The present disclosure is in relation to the use of a composition comprising pentameric type A procyanidin, trimeric procyanidin and tetrameric procyanidin, optionally along with pharmaceutical excipient(s), in management of broncho-constrictive conditions such as Allergic Rhinitis, Asthma, and Chronic obstructive pulmonary disease (COPD).Type: GrantFiled: July 27, 2011Date of Patent: October 22, 2013Assignee: Indus Biotech Private LimitedInventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Patent number: 8513203Abstract: The present disclosure relates to a composition comprising Trigoneoside Ib and Vicenin-1 for treatment and management of Goodpasture's disease, Glomerulonephritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus and Idiopathic Thrombocytopenia Purpura. The present disclosure also relates to a method of obtaining the said composition from Trigonella foenum-graecum.Type: GrantFiled: June 14, 2011Date of Patent: August 20, 2013Assignee: Indus Biotech Private LimitedInventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Publication number: 20120282332Abstract: The present disclosure relates to a composition comprising Trigoneoside Ib and Vicenin-1 for treatment and management of Goodpasture's disease, Glomerulonephritis, Rheumatoid Arthritis, Systemic Lupus Erythematosus and Idiopathic Thrombocytopenia Purpura. The present disclosure also relates to a method of obtaining the said composition from Trigonella foenum-graecum.Type: ApplicationFiled: June 14, 2011Publication date: November 8, 2012Applicant: INDUS BIOTECH PRIVATE LIMITEDInventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Patent number: 8288364Abstract: The present invention relates to a novel botanical compound as provided in structural formula I optionally along with excipients for improving body composition and the factors related to the pre-diabetic and diabetic conditions. It also relates to a process of manufacture of the novel botanical compound for improving body composition and factors related to the pre-diabetic and diabetic conditions. The present invention also relates to the use of the novel botanical compound for improving body composition, reducing body fat, increasing muscle mass, enhancing strength and improving impaired glucose metabolism. The present invention also relates to the use of the novel botanical compound for the improvement of factors related to the pre-diabetic and diabetic conditions.Type: GrantFiled: May 9, 2008Date of Patent: October 16, 2012Assignee: Indus Biotech Private LimitedInventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Publication number: 20120201876Abstract: The present disclosure relates to treatment and management of Cushing's syndrome, Headache disorders and Neuropathic using a composition comprising asiaticoside and madecasosside optionally along with at least one excipient. The treatment can be extended to Myalgia and other related disease conditions.Type: ApplicationFiled: August 2, 2011Publication date: August 9, 2012Inventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Publication number: 20120190736Abstract: The present disclosure is in relation to the use of a composition comprising pentameric type A procyanidin, trimeric procyanidin and tetrameric procyanidin, optionally along with pharmaceutical excipient(s), in management of broncho-constrictive conditions such as Allergic Rhinitis, Asthma, and Chronic obstructive pulmonary disease (COPD).Type: ApplicationFiled: July 27, 2011Publication date: July 26, 2012Inventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Publication number: 20120148504Abstract: The present disclosure discloses a pharmaceutical molecule of Garcinol chemically complexed with cyclodextrins and the use of the complexed molecule in prevention and management of cardiac dysfunction induced by chemotherapy, drugs and/or other insults to the heart caused by lifestyle and disease conditions. The disclosure also relates to a method of extraction and purification of high yield of 95-99% pure Garcinol from Garcinia species and a method of chemically complexing Garcinol with cyclodextrins to improve its stability and bioavailability.Type: ApplicationFiled: January 28, 2011Publication date: June 14, 2012Applicant: INDUS BIOTECH PRIVATE LIMITEDInventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Publication number: 20110144053Abstract: The present invention relates to a process of extraction and purification of a stilbenoid, pterostilbene, from botanical sources. The process involves obtaining pterostilbene having high degree of purity and the present invention also relates to pure form of pterostilbene obtained. The invention also relates to complexing the pterostilbene with carriers such as cyclodextrin for improving its water solubility and bioavailability. The present invention also describes a process for inhibition of Histone Deacetylases using pterostilbene optionally along with a carrier, and a method of managing Poly Glutamine repeat disorders by the administration of pterostilbene optionally along with a carrier.Type: ApplicationFiled: July 30, 2009Publication date: June 16, 2011Inventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Publication number: 20110039923Abstract: The present disclosure is in relation to antiviral preparations obtained from plant sources namely Cinnamon, Litchi and Arachis. It provides a composition and a process to prepare the composition comprising pentameric procyanidin flavonoid, trimers and tetramers. The composition improves immunity response and found to be useful in treatment and management of HIV infection and AIDS and for the prevention, treatment and management of Influenza virus and infection.Type: ApplicationFiled: September 24, 2009Publication date: February 17, 2011Applicant: Indus Biotech Private LimitedInventors: Sunil BHASKARAN, Mohan VISHWARAMAN
-
Publication number: 20090281057Abstract: The present invention relates to a novel botanical compound as provided in structural formula I optionally along with excipients for improving body composition and the factors related to the pre-diabetic and diabetic conditions. It also relates to a process of manufacture of the novel botanical compound for improving body composition and factors related to the pre-diabetic and diabetic conditions. The present invention also relates to the use of the novel botanical compound for improving body composition, reducing body fat, increasing muscle mass, enhancing strength and improving impaired glucose metabolism. The present invention also relates to the use of the novel botanical compound for the improvement of factors related to the pre-diabetic and diabetic conditions.Type: ApplicationFiled: May 9, 2008Publication date: November 12, 2009Applicant: INDUS BIOTECH PRIVATE LIMITEDInventors: Sunil BHASKARAN, Mohan VISHWARAMAN
-
Publication number: 20090012014Abstract: The present invention provides a novel steroidal glycoside for management of rheumatic and inflammatory disease conditions. In addition, the present invention also provides a process for preparation of steroidal glycoside from plant fenugreek. Further, the invention also provides a pharmaceutical composition of the steroidal glycoside for management of rheumatic disease conditions and its associated disorders.Type: ApplicationFiled: August 3, 2007Publication date: January 8, 2009Applicant: INDUS BIOTECH PVT. LTDInventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Publication number: 20080221173Abstract: The present invention relates to a pharmaceutical composition having dopaminergic activity and other related pharmaceutical activities comprising trigonelline or its derivative(s) and 4-hydroxyisoleucine or its derivative(s), optionally along with excipients(s); a process of preparing a pharmaceutical composition comprising trigonelline or its derivative(s) and 4-hydroxyisoleucine or its derivative(s), optionally along with excipients(s), wherein the process comprising steps of: (a) extracting a clear solution containing trigonelline and 4-hydroxyisoleucine from plant source; and (b) optionally precipitating derivative(s) of trigonelline and 4-hydroxyisoleucine from the clear solution and obtaining said composition; and an in-vitro method to increase levels of dopamine or to inhibit prolactin by allowing composition comprising trigonelline or its derivative(s) and 4-hydroxyisoleucine or its derivative(s) to bind to cell receptors.Type: ApplicationFiled: March 3, 2008Publication date: September 11, 2008Applicant: Indus Biotech Pvt. Ltd.Inventors: Sunil Bhaskaran, Mohan Vishwaraman
-
Publication number: 20080194499Abstract: The present invention relates to a novel pharmaceutical composition for serotonin reuptake inhibition, wherein the composition comprises pentacyclic terpenoid glycosides, preferably asiaticoside and madecassoside optionally along with excipients. Also the present invention relates to a process of preparation of novel pharmaceutical composition for serotonin reuptake inhibition, wherein the process comprising steps of: (a) obtaining extract from the plant Centella asiatica; (b) treating the extract with the solvents to remove fatty substances, chlorophyll and other colorants; (c) purifying the extract through HPLC to obtain the eluted solvent; and (d) concentrating the eluted solvent to arrive at the composition. The invention also relates to the use of a composition comprising pentacyclic terpenoid glycosides, preferably asiaticoside and madecassoside optionally along with excipients to manufacture a medicament for serotonin reuptake inhibition in a subject in need thereof.Type: ApplicationFiled: February 12, 2008Publication date: August 14, 2008Applicant: INDUS BIOTECH PRIVATE LIMITEDInventors: Sunil Bhaskaran, Mohan Vishwaraman